EYE DROPS; INSURANCE COVERAGE                                                     H.B. 4451 (H-1):

                                                                                                    SUMMARY OF BILL

                                                                                     REPORTED FROM COMMITTEE

 

 

 

 

 

 

 

 

 

House Bill 4451 (Substitute H-1 as reported without amendment)

Sponsor:  Representative Julie Calley

House Committee:  Health Policy

                             Ways and Means

Senate Committee:  Health Policy and Human Services

 


CONTENT

 

The bill would amend the Insurance Code to prohibit an insurer that delivered, issued for delivery, or renewed in the State a health insurance policy that provided coverage for prescription eye drops from denying coverage for a refill of the prescription if the following applied:

 

 --    For a 30-day supply, the amount of time had passed within which the insured should have used 75% of the dosage units of the drug according to the prescriber's instructions, or 23 days had passed after either: 1) the original date the prescription was distributed to the insured, or 2) the date the most recent refill was distributed to the insured.

 --    The prescriber indicated on the original prescription that additional quantities were needed.

 --    The prescription eye drops prescribed by the prescriber were covered under the health insurance policy.

 

Proposed MCL 500.3406u                                          Legislative Analyst:  Tyler VanHuyse

 

FISCAL IMPACT

 

The bill would have no fiscal impact on State or local government.

 

Date Completed:  10-25-19                                      Fiscal Analyst:  Elizabeth Raczkowski

                                                                                                         Steve Angelotti

 

 

 

 

This analysis was prepared by nonpartisan Senate staff for use by the Senate in its deliberations and does not constitute an official statement of legislative intent.